DarioHealth Corp. (DRIO) vs Renalytix plc - Sponsored ADR (RNLXY)

DarioHealth Corp. and Renalytix plc - Sponsored ADR are both Health Information Services companies. DarioHealth Corp. is the larger, with a market value of $50.3M against $17.2M — 2.9× the size. Renalytix plc - Sponsored ADR grew revenue faster over the last twelve months: −18.3% against −22.7%. DarioHealth Corp. has the higher net margin (−215.6% vs −1,695.9%) and the lower return on invested capital (−27.7% vs 0.00%). Across the 16 metrics below, Renalytix plc - Sponsored ADR leads on 10 and DarioHealth Corp. on 6.

Valuation

Metric DRIO RNLXY Health Information Services median
P/E n/m n/m 39.82
P/S 2.20 3.13 2.24
P/B 0.84 n/m 1.79
Price to free cash flow n/m n/m 19.04
EV/EBITDA n/m n/m 11.52
EV/Sales 3.49 2.50 2.64
Earnings yield (123.84%) (510.83%) (2.45%)
Free cash flow yield (55.86%) (312.02%) 0.00%

Profitability

Metric DRIO RNLXY Health Information Services median
Gross margin 58.15% 14.52% 62.87%
Operating margin (151.60%) (1,087.73%) (9.45%)
Net margin (215.63%) (1,695.90%) (15.48%)
Free cash flow margin (121.32%) 0.00% 0.00%
Return on equity (76.05%) 0.00% (6.91%)
Return on assets (44.19%) 0.00% (6.28%)
Return on invested capital (27.67%) 0.00% 0.00%

Growth

Metric DRIO RNLXY Health Information Services median
Revenue growth (TTM) (22.65%) (18.32%) 8.78%
EPS growth (last fiscal year) 41.95% 82.14% 57.06%
Revenue growth, 5-year CAGR 24.17% — 11.91%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DRIO RNLXY Health Information Services median
Debt to equity 0.56 (5.99) 0.00
Current ratio 2.31 2.43 2.31
Net debt to EBITDA (0.13) (0.26) 0.48

Dividend

Metric DRIO RNLXY Health Information Services median
Dividend yield — — —
Payout ratio — — —

Size

Metric DRIO RNLXY Health Information Services median
Market cap 50.27m 17.18m 332.37m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack